Ref.: BL-RE-093218Manufacturer ref.: EHCEAX10 10 x 96 tests
€4,815.00 excl. VAT
CEA is synthesized in the fetus intestine during development and is again expressed in higher amounts in intestinal carcinomas and several other tumours. CEA is a member of the supergene family of the...
Accession number
P06731
Dose range
0.343 to 250 ng/ml
Sensitivity of the dosage
200 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
CEA is synthesized in the fetus intestine during development and is again expressed in higher amounts in intestinal carcinomas and several other tumours. CEA is a member of the supergene family of the...
CEA is synthesized in the fetus intestine during development and is again expressed in higher amounts in intestinal carcinomas and several other tumours. CEA is a member of the family of immunoglobulin supergens, carcinoembryonic antigens, and consists of a single domain N and six domains of constant-type immunoglobulin A (A1, A2, A3) and B (B1, B2, B3). The ACE antibodies are useful in identifying the origin of the various metastatic adenocarcinomas and distinguishing between pulmonary adenocarcinomas (60-70% are CEA+) and pleural mesotheliomas (rarely or weakly CEA+). CEA is part of the large glycoprotein family, a tumour marker useful for adenocarcinoma, and found in the epithelium adenocarcinomas of the digestive system derived from lhe endoderma and the colon of the foetus. Two subgroups of the CEA family, CEA cell adhesion molecules and pregnancy-specific glycoproteins, are located in a 1.2 Mb group on the long arm of chromosome 19. Eleven pseudogenes from the CEA cell adhesion molecules subgroup are also present in the group. CEA was initially described in the liver bile canals as biliary glycoprotein. Subsequently, it was shown that CEA is a cell adhesion molecule detected on leukocytes, l'épithelium, and l'endothelium. Several transcription variants coding different isoforms were recorded, but the full length nature of all variants was not defined.
Sensitivity
Sensitivity of the dosage: 200 pg/ml.
Measurement range
Dose range: 0.343 to 250 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Coefficient of intradose variation < 10%, interdose < 12%.